Skip to content

Clinical trials

Completed Observational Hyperlipoproteinemia Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Phase: Observational Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20101
20111
20121
20141
20165
20175
20192
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon2
Organon and Co2
University of Pennsylvania2
Amgen1
Ankara Yildirim Beyazıt University1
Ege University1
Emory University1
Fresenius Medical Care Deutschland GmbH1
GWT-TUD GmbH1
Heart Care Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II24
Hypercholesterolemia5
Cardiovascular Diseases4
Atherosclerosis3
Homozygous Familial Hypercholesterolemia2
Angina Pectoris1
Coronary Artery Disease1
Coronary Disease1
Diabetes Mellitus1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.